214 related articles for article (PubMed ID: 14623961)
1. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis.
Mourez M; Yan M; Lacy DB; Dillon L; Bentsen L; Marpoe A; Maurin C; Hotze E; Wigelsworth D; Pimental RA; Ballard JD; Collier RJ; Tweten RK
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13803-8. PubMed ID: 14623961
[TBL] [Abstract][Full Text] [Related]
2. Identification of new dominant-negative mutants of anthrax protective antigen using directed evolution.
Wu G; Feng C; Cao S; Guo A; Liu Z
Appl Biochem Biotechnol; 2012 Nov; 168(5):1302-10. PubMed ID: 22948605
[TBL] [Abstract][Full Text] [Related]
3. Membrane insertion by anthrax protective antigen in cultured cells.
Qa'dan M; Christensen KA; Zhang L; Roberts TM; Collier RJ
Mol Cell Biol; 2005 Jul; 25(13):5492-8. PubMed ID: 15964805
[TBL] [Abstract][Full Text] [Related]
4. An approach to characterizing single-subunit mutations in multimeric prepores and pores of anthrax protective antigen.
Janowiak BE; Finkelstein A; Collier RJ
Protein Sci; 2009 Feb; 18(2):348-58. PubMed ID: 19165720
[TBL] [Abstract][Full Text] [Related]
5. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.
Sun J; Lang AE; Aktories K; Collier RJ
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4346-51. PubMed ID: 18334631
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dominant-negative forms of anthrax protective antigen.
Yan M; Collier RJ
Mol Med; 2003; 9(1-2):46-51. PubMed ID: 12765339
[TBL] [Abstract][Full Text] [Related]
7. A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo.
Singh Y; Khanna H; Chopra AP; Mehra V
J Biol Chem; 2001 Jun; 276(25):22090-4. PubMed ID: 11278644
[TBL] [Abstract][Full Text] [Related]
8. Anthrax protective antigen: prepore-to-pore conversion.
Miller CJ; Elliott JL; Collier RJ
Biochemistry; 1999 Aug; 38(32):10432-41. PubMed ID: 10441138
[TBL] [Abstract][Full Text] [Related]
9. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
[TBL] [Abstract][Full Text] [Related]
10. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.
Cunningham K; Lacy DB; Mogridge J; Collier RJ
Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439
[TBL] [Abstract][Full Text] [Related]
11. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.
Zhang J; Xu J; Li G; Dong D; Song X; Guo Q; Zhao J; Fu L; Chen W
Biochem Biophys Res Commun; 2006 Mar; 341(4):1164-71. PubMed ID: 16460675
[TBL] [Abstract][Full Text] [Related]
12. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
[TBL] [Abstract][Full Text] [Related]
13. Role of residues constituting the 2beta1 strand of domain II in the biological activity of anthrax protective antigen.
Khanna H; Chopra AP; Arora N; Chaudhry A; Singh Y
FEMS Microbiol Lett; 2001 May; 199(1):27-31. PubMed ID: 11356563
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.
Salles II; Voth DE; Ward SC; Averette KM; Tweten RK; Bradley KA; Ballard JD
Cell Microbiol; 2006 Aug; 8(8):1272-81. PubMed ID: 16882031
[TBL] [Abstract][Full Text] [Related]
16. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
Gupta M; Alam S; Bhatnagar R
Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
[TBL] [Abstract][Full Text] [Related]
17. Membrane translocation by anthrax toxin.
Collier RJ
Mol Aspects Med; 2009 Dec; 30(6):413-22. PubMed ID: 19563824
[TBL] [Abstract][Full Text] [Related]
18. Characterization of membrane translocation by anthrax protective antigen.
Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
[TBL] [Abstract][Full Text] [Related]
19. Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin.
Mogridge J; Mourez M; Collier RJ
J Bacteriol; 2001 Mar; 183(6):2111-6. PubMed ID: 11222612
[TBL] [Abstract][Full Text] [Related]
20. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
